KYMERA THERAPEUTICS INC (KYMR) Stock Earnings & Estimates
NASDAQ:KYMR - US5015751044 - Common Stock
43.46 USD
-0.05 (-0.11%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 46.83M -35.70% | 78.592M 67.82% | 47.072M -40.11% | 74.586M 58.45% | 57.405M -23.04% | 52.062M -9.31% | 43.634M -16.19% | 66.382M 52.13% | 294.6M 343.80% | 481.83M 63.55% | 2.703B 460.99% | |
| EBITDA YoY % growth | -158.28M -61.30% | -161.965M -2.33% | -249.337M -53.94% | -283.327M -13.63% | -358.082M -26.38% | -418.674M -16.92% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -161.26M -60.41% | -165.53M -2.65% | -256.71M -55.08% | -312.778M -21.84% | -377.515M -20.70% | -422.175M -11.83% | -440.285M -4.29% | -475.776M -8.06% | -317.537M 33.26% | -116.694M 63.25% | 1.636B 1,501.96% | |
| Operating Margin | -344.35% | -210.62% | -545.36% | -419.35% | -657.63% | -810.91% | -1,009.04% | -716.72% | -107.79% | -24.22% | 60.53% | |
| EPS YoY % growth | -2.88 -39.81% | -2.52 12.50% | -2.90 -15.08% | -3.48 -20.12% | -4.18 -19.93% | -4.44 -6.24% | -4.68 -5.44% | -4.00 14.46% | -2.05 48.74% | -0.39 81.11% | 15.94 4,212.63% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.81 0.64% | -0.88 0.14% | -1.10 -33.93% | -1.17 -23.29% | -1.13 -38.71% | -1.20 -36.73% |
| Revenue Q2Q % growth | 20.04M 435.69% | 17.871M 141.70% | 11.135M -49.62% | 9.775M -14.82% | 11.73M -41.47% | 7.65M -57.19% |
| EBITDA Q2Q % growth | -76.788M -15.06% | -87.185M -18.81% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -79.022M -9.56% | -83.854M -3.84% | -94.996M -27.64% | -100.436M -18.78% | -102.612M -29.85% | -110.629M -31.93% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.95 -63.79% | -0.83 | -0.12 | -14.98% |
| Q1 2025 Q2Q % growth | -0.82 -32.26% | -0.93 | 0.11 | 12.26% |
| Q4 2024 Q2Q % growth | -0.88 -252.00% | -0.79 | -0.09 | -11.39% |
| Q3 2024 Q2Q % growth | -0.82 8.89% | -0.86 | 0.04 | 4.15% |
| Q2 2024 Q2Q % growth | -0.58 13.43% | -0.70 | 0.12 | 16.79% |
| Q1 2024 Q2Q % growth | -0.62 11.43% | -0.74 | 0.12 | 16.38% |
| Q4 2023 Q2Q % growth | -0.25 58.33% | -0.41 | 0.16 | 39.48% |
| Q3 2023 Q2Q % growth | -0.90 -13.92% | -0.65 | -0.25 | -37.58% |
| Q2 2023 Q2Q % growth | -0.67 14.10% | -0.65 | -0.02 | -3.17% |
| Q1 2023 Q2Q % growth | -0.70 1.41% | -0.69 | -0.01 | -1.30% |
| Q4 2022 Q2Q % growth | -0.60 9.09% | -0.65 | 0.05 | 7.09% |
| Q3 2022 Q2Q % growth | -0.79 -41.07% | -0.73 | -0.06 | -7.82% |
| Q2 2022 Q2Q % growth | -0.78 -41.82% | -0.70 | -0.08 | -10.73% |
| Q1 2022 Q2Q % growth | -0.71 -144.83% | -0.68 | -0.03 | -5.13% |
| Q4 2021 Q2Q % growth | -0.66 -127.59% | -0.58 | -0.08 | -13.72% |
| Q3 2021 Q2Q % growth | -0.56 -43.59% | -0.43 | -0.13 | -29.64% |
| Q2 2021 Q2Q % growth | -0.55 | -0.29 | -0.26 | -86.69% |
| Q1 2021 Q2Q % growth | -0.29 | -0.15 | -0.14 | -91.88% |
| Q4 2020 Q2Q % growth | -0.29 | -0.04 | -0.25 | -576.94% |
| Q3 2020 Q2Q % growth | -0.39 | -0.21 | -0.18 | -82.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 11.476M -55.26% | 23.855M | -12.379M | -51.89% |
| Q1 2025 Q2Q % growth | 22.1M 114.83% | 10.358M | 11.742M | 113.36% |
| Q4 2024 Q2Q % growth | 7.394M -84.56% | 12.056M | -4.662M | -38.67% |
| Q3 2024 Q2Q % growth | 3.741M -20.88% | 10.567M | -6.826M | -64.60% |
| Q2 2024 Q2Q % growth | 25.65M 55.33% | 12.805M | 12.845M | 100.31% |
| Q1 2024 Q2Q % growth | 10.287M 8.67% | 13.961M | -3.674M | -26.32% |
| Q4 2023 Q2Q % growth | 47.884M 196.68% | 42.801M | 5.083M | 11.88% |
| Q3 2023 Q2Q % growth | 4.728M -50.49% | 16.292M | -11.564M | -70.98% |
| Q2 2023 Q2Q % growth | 16.513M 43.47% | 14.339M | 2.174M | 15.16% |
| Q1 2023 Q2Q % growth | 9.466M -1.60% | 14.437M | -4.971M | -34.43% |
| Q4 2022 Q2Q % growth | 16.14M 5.63% | 22.012M | -5.872M | -26.68% |
| Q3 2022 Q2Q % growth | 9.55M -53.05% | 15.823M | -6.273M | -39.64% |
| Q2 2022 Q2Q % growth | 11.51M -37.85% | 14.522M | -3.012M | -20.74% |
| Q1 2022 Q2Q % growth | 9.62M -48.56% | 16.56M | -6.94M | -41.91% |
| Q4 2021 Q2Q % growth | 15.28M 19.47% | 21.739M | -6.459M | -29.71% |
| Q3 2021 Q2Q % growth | 20.34M 39.99% | 20.003M | 337K | 1.68% |
| Q2 2021 Q2Q % growth | 18.52M 175.76% | 19.191M | -671K | -3.50% |
| Q1 2021 Q2Q % growth | 18.7M | 19.433M | -733K | -3.77% |
| Q4 2020 Q2Q % growth | 12.79M 598.91% | 22.032M | -9.242M | -41.95% |
| Q3 2020 Q2Q % growth | 14.53M 1,429.47% | 18.36M | -3.83M | -20.86% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 11.89% | 3.1% | 2.3% | 5.74% |
| Revenue | 16.76% | 22.17% | 0.12% | 10.51% |